Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern Norway

References

• Moum B, Vatn MH, Ekbom A, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol. 1996;31(4):362–366.
   PubMed Web of Science ®Google Scholar
• Solberg IC, Lygren I, Jahnsen J, IBSEN Study Group, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44(4):431–440.
   PubMed Web of Science ®Google Scholar
• Solberg IC, Vatn MH, Hoie O, et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5(12):1430–1438.
   PubMed Web of Science ®Google Scholar
• Froslie KF, Jahnsen J, Moum BA, et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133(2):412–422.
   PubMed Web of Science ®Google Scholar
• Solberg IC, Cvancarova M, Vatn MH, et al. Risk matrix for prediction of advanced disease in a population-based study of patients with Crohn's Disease (the IBSEN Study). Inflamm Bowel Dis. 2014; 20:60–68.
   PubMed Web of Science ®Google Scholar
• Kristensen VA, Cvancarova M, Hoivik ML, et al. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study. Scand J Gastroenterol. 2020;55(4):436–441.
   PubMed Web of Science ®Google Scholar
• Hovde O, Kempski-Monstad I, Smastuen MC, et al. Mortality and causes of death in Crohn's disease: results from 20 years of follow-up in the IBSEN study. Gut. 2014;63(5):771–775.
   PubMed Web of Science ®Google Scholar
• Colombel JF, D'Haens G, Lee WJ, et al. Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review. J Crohns Colitis. 2020;14(2):254–266.
   PubMed Web of Science ®Google Scholar
• Cleynen I, Boucher G, Jostins L, International Inflammatory Bowel Disease Genetics Consortium, et al. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2016;387(10014):156–167.
   PubMed Web of Science ®Google Scholar
• Coskun M, Vermeire S, Nielsen OH. Novel targeted therapies for inflammatory bowel disease. Trends Pharmacol Sci. 2017;38(2):127–142.
   PubMed Web of Science ®Google Scholar
• Moum B, Ekbom A, Vatn MH, et al. Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway. Gut. 1997;40(3):328–332.
   PubMed Web of Science ®Google Scholar
• Sjoberg D, Holmstrom T, Larsson M, et al. Incidence and clinical course of Crohn's disease during the first year - results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009. Journal of Crohn's & Colitis. 2014;8(3):215–222.
   PubMed Web of Science ®Google Scholar
• Jussila A, Virta LJ, Kautiainen H, et al. Increasing incidence of inflammatory bowel diseases between 2000 and 2007: a nationwide register study in Finland. Inflamm Bowel Dis. 2012;18(3):555–561.
   PubMed Web of Science ®Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989; 170:2–6.
   PubMedGoogle Scholar
• Levine A, Koletzko S, Turner D, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58(6):795–806.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749–753.
   PubMed Web of Science ®Google Scholar
• Chaparro M, Barreiro-de Acosta M, Benítez JM, EpidemIBD study group of GETECCU, et al. EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain. Therap Adv Gastroenterol. 2019;12:1756284819847034.
   Web of Science ®Google Scholar
• Pittet V, Juillerat P, Mottet C, Swiss IBD Cohort Study Group, et al. Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Int J Epidemiol. 2009;38(4):922–931.
   PubMed Web of Science ®Google Scholar
• Burisch J, Cukovic-Cavka S, Kaimakliotis I, et al. Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe an EpiCom study. Journal of Crohn's & Colitis. 2011;5(4):342–349.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999;149(10):916–924.
   PubMed Web of Science ®Google Scholar
• Benjaminsen E, Myhr KM, Grytten N, et al. Validation of the multiple sclerosis diagnosis in the Norwegian Patient Registry. Brain Behav. 2019;9(11):e01422.
   PubMed Web of Science ®Google Scholar
• Jakobsson GL, Sternegård E, Olén O, et al. Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG). Scand J Gastroenterol. 2017;52(2):216–221.
   PubMed Web of Science ®Google Scholar
• Colombel JF, Narula N, Peyrin-Biroulet L. Management strategies to improve outcomes of patients with inflammatory bowel diseases. Gastroenterology. 2017;152(2):351–361.
   PubMed Web of Science ®Google Scholar